What are the early signs of Multiple Myeloma recurrence
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Early Signs of Multiple Myeloma Recurrence
Multiple myeloma recurrence—when the cancer comes back after treatment—is an important concern to monitor. Let me explain what to watch for and how doctors detect it.
What Recurrence Means
According to NCCN Guidelines, relapse occurs when myeloma comes back after being in remission (when signs and symptoms decrease or disappear). This is different from progression, which is when cancer doesn't improve or becomes worse during active treatment.
Early Warning Signs You Might Notice
While some recurrence is detected through lab tests before you feel symptoms, watch for these physical signs:
Bone-related symptoms:
- Increased bone pain (especially in the back, ribs, or pelvis)
- New or worsening bone pain in areas that were previously stable
- Increased risk of fractures or breaks
Blood-related symptoms:
- Unusual fatigue or weakness that's worse than before
- Increased infections or fever
- Easy bruising or bleeding
- Shortness of breath
General symptoms:
- Increased thirst and frequent urination (sign of high calcium levels)
- Nausea or loss of appetite
- Numbness or tingling in hands/feet
How Doctors Detect Recurrence Early
The most important thing to know: Doctors often catch recurrence before you feel symptoms through routine monitoring tests. According to NCCN Guidelines, follow-up testing typically includes:
Blood tests (done at least every 3 months):
- M protein levels in your blood (serum protein electrophoresis or SPEP)
- Free light chain assay
- Complete blood count (CBC)
- Blood chemistry tests to check kidney and bone health
Urine tests:
- M proteins and light chains in 24-hour urine collection
Imaging (annually or as clinically indicated):
- Whole-body MRI, low-dose CT, or PET/CT scans
- These can detect new bone lesions before you have symptoms
Bone marrow testing:
- May be done at relapse with FISH testing to check for genetic changes
Why Early Detection Matters
Catching recurrence early—through these scheduled tests—gives your care team time to start new treatment before you develop serious symptoms. This is why keeping all your follow-up appointments is critical, even when you're feeling well.
Questions to Ask Your Care Team
- How often should I have follow-up tests, and what tests specifically?
- What M protein level or lab value would indicate recurrence in my case?
- If recurrence is detected, what treatment options would be available to me?
- Are there any symptoms I should report immediately between appointments?
- Should I be doing anything at home to monitor my health?
Important Context
According to NCCN Guidelines, myeloma "usually comes back and requires additional treatment." This is a normal part of the disease course, not a failure of your initial treatment. The good news is that there are many treatment options available for relapsed myeloma, including newer therapies like CAR T-cell therapy and bispecific antibodies, especially after you've tried 3-4 prior therapies.
Your oncologist will determine the most appropriate approach for YOUR case based on:
- How long you've been in remission
- Which treatments you've already received
- Your current health status
- Genetic features of your myeloma
- Your goals and preferences
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Multiple Myeloma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with prognosis for Multiple Myeloma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What is the life expectancy for multiple myeloma cancer
I understand this is one of the most important questions you might have. Let me share what the current medical evidence shows, while being clear about
What is the 5-year survival rate for multiple myeloma
I appreciate this important question, but I need to be transparent with you: the NCCN Guidelines for Patients materials I have access to don't include
What is the average survival rate for multiple myeloma by stage
I appreciate this important question. However, I need to be direct with you: the NCCN Guidelines for Patients that I have access to do not include spe